MESO logo

Mesoblast Limited (MESO) EBITDA

Annual EBITDA

-$62.82 M
-$4.27 M-7.30%

June 30, 2024

Summary

Performance

1-Year Change

-7.3%

3-Year Change

+25.79%

5-Year Change

+25.68%

15-Year Change

+27.92%

MESO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.38%
MESO annual EBITDA is higher than 28.38% of companies in Healthcare sector

High & Low

All-time High

$92.44 M
MESO annual EBITDA is currently -167.96% below its historical high of $92.44 million

3-Year Low

-$84.65 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
MESO previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
MESO next annual earnings announcement has not yet been scheduled

OtherMESOprofitabilitymetrics:

Annual Revenue

$5.90 M
MESO annual revenue is $5.90 million

Annual Net Income

-$87.96 M
MESO annual net profit is -$87.96 million

Annual EBIT

-$67.49 M
MESO annual earnings before interest & taxes is -$67.49 million

Annual EPS

-$89.10
MESO annual earnings per share is -$89.10

Quarterly EBITDA

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

MESO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$3.96 M
MESO quarterly EBITDA is currently at an all-time high

3-Year Low

-$20.86 M
MESO quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
MESO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
MESO next earnings announcement is scheduled for Feb 28, 2025

OtherMESOprofitabilitymetrics:

Quarterly Revenue

-
MESO quarterly revenue value is unknown

Quarterly Net Income

-
MESO quarterly net profit value is unknown

Quarterly EBIT

-
MESO quarterly earnings before interest & taxes value is unknown

Quarterly EPS

-
MESO quarterly earnings per share value is unknown

TTM EBITDA

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

MESO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$25.22 M
MESO TTM EBITDA is currently at an all-time high

3-Year Low

-$82.07 M
MESO TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
MESO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
MESO next earnings announcement is scheduled for Feb 28, 2025

OtherMESOprofitabilitymetrics:

TTM Revenue

-
MESO TTM revenue value is unknown

TTM Net Income

-
MESO TTM net profit value is unknown

TTM EBIT

-
MESO TTM earnings before interest & taxes value is unknown

TTM EPS

-
MESO TTM earnings per share value is unknown

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$62.82 M
MESO annual EBITDA is -$62.82 million

Annual Net Income

-$87.96 M
MESO annual net profit is -$87.96 million

Annual Interest Expense

$20.66 M
MESO annual interest expense is $20.66 million

Annual Income Tax

-$191.00 K
MESO annual income tax is -$191.00 thousand

Annual D&A

$4.67 M
MESO annual depreciation & amortization is $4.67 million

MESO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-7.3%--
3 y3 years+25.8%--
5 y5 years+25.7%--

MESO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-7.3%+25.8%
5 y5-year-7.3%+25.8%
alltimeall time-168.0%+30.0%

Mesoblast Limited EBITDA History

DateAnnualQuarterlyTTM
Jun 2024
-$62.82 M(+7.3%)
-
-
Jun 2023
-$58.55 M(-16.3%)
-$17.26 M(+36.2%)
-$59.78 M(+2.0%)
Mar 2023
-
-$12.67 M(-31.8%)
-$58.62 M(-5.9%)
Dec 2022
-
-$18.57 M(+64.6%)
-$62.27 M(-3.5%)
Sep 2022
-
-$11.28 M(-29.9%)
-$64.56 M(-8.7%)
Jun 2022
-$69.92 M(-17.4%)
-$16.10 M(-1.4%)
-$70.75 M(-7.9%)
Mar 2022
-
-$16.32 M(-21.8%)
-$76.81 M(-6.4%)
Dec 2021
-
-$20.86 M(+19.4%)
-$82.07 M(-0.9%)
Sep 2021
-
-$17.47 M(-21.1%)
-$82.83 M(-5.6%)
Jun 2021
-$84.65 M(+22.7%)
-$22.15 M(+2.7%)
-$87.73 M(-9.2%)
Mar 2021
-
-$21.58 M(-0.2%)
-$96.63 M(+10.3%)
Dec 2020
-
-$21.62 M(-3.3%)
-$87.59 M(-1.8%)
Sep 2020
-
-$22.37 M(-28.0%)
-$89.22 M(+26.0%)
Jun 2020
-$68.97 M(-18.4%)
-$31.06 M(+147.7%)
-$70.81 M(+19.3%)
Mar 2020
-
-$12.54 M(-46.1%)
-$59.34 M(-15.6%)
Dec 2019
-
-$23.25 M(+487.3%)
-$70.31 M(-1.7%)
Sep 2019
-
-$3.96 M(-79.8%)
-$71.49 M(-15.4%)
Jun 2019
-$84.53 M(+37.5%)
-$19.59 M(-16.6%)
-$84.54 M(-1.0%)
Mar 2019
-
-$23.50 M(-3.8%)
-$85.39 M(-0.7%)
Dec 2018
-
-$24.44 M(+43.7%)
-$86.03 M(+21.8%)
Sep 2018
-
-$17.00 M(-16.9%)
-$70.63 M(+12.3%)
Jun 2018
-$61.50 M
-$20.45 M(-15.3%)
-$62.92 M(-14.7%)
Mar 2018
-
-$24.14 M(+167.1%)
-$73.72 M(+18.0%)
DateAnnualQuarterlyTTM
Dec 2017
-
-$9.04 M(-2.7%)
-$62.46 M(-17.4%)
Sep 2017
-
-$9.29 M(-70.3%)
-$75.62 M(-13.5%)
Jun 2017
-$87.16 M(-1.7%)
-$31.26 M(+142.7%)
-$87.44 M(-9.5%)
Mar 2017
-
-$12.88 M(-42.0%)
-$96.62 M(-5.1%)
Dec 2016
-
-$22.20 M(+5.2%)
-$101.78 M(+2.3%)
Sep 2016
-
-$21.11 M(-47.8%)
-$99.44 M(+12.2%)
Jun 2016
-$88.63 M(-1.3%)
-$40.44 M(+124.3%)
-$88.63 M(+15.7%)
Mar 2016
-
-$18.03 M(-9.2%)
-$76.61 M(-2.3%)
Dec 2015
-
-$19.86 M(+92.9%)
-$78.38 M(-6.4%)
Sep 2015
-
-$10.30 M(-63.8%)
-$83.74 M(+14.0%)
Jun 2015
-$89.78 M(+27.5%)
-$28.42 M(+43.5%)
-$73.44 M(+63.1%)
Mar 2015
-
-$19.80 M(-21.5%)
-$45.02 M(+78.5%)
Dec 2014
-
-$25.22 M
-$25.22 M
Jun 2014
-$70.43 M(+18.8%)
-
-
Jun 2013
-$59.31 M(+22.7%)
-
-
Jun 2012
-$48.34 M(-152.3%)
-
-
Jun 2011
$92.44 M(-731.9%)
-
-
Jun 2010
-$14.63 M(+46.1%)
-
-
Jun 2009
-$10.01 M(+28.7%)
-
-
Jun 2008
-$7.78 M(+12.0%)
-
-
Jun 2007
-$6.95 M(-14.7%)
-
-
Jun 2006
-$8.14 M(+505.9%)
-
-
Jun 2005
-$1.34 M
-
-

FAQ

  • What is Mesoblast Limited annual EBITDA?
  • What is the all time high annual EBITDA for Mesoblast Limited?
  • What is Mesoblast Limited annual EBITDA year-on-year change?
  • What is the all time high quarterly EBITDA for Mesoblast Limited?
  • What is the all time high TTM EBITDA for Mesoblast Limited?

What is Mesoblast Limited annual EBITDA?

The current annual EBITDA of MESO is -$62.82 M

What is the all time high annual EBITDA for Mesoblast Limited?

Mesoblast Limited all-time high annual EBITDA is $92.44 M

What is Mesoblast Limited annual EBITDA year-on-year change?

Over the past year, MESO annual EBITDA has changed by -$4.27 M (-7.30%)

What is the all time high quarterly EBITDA for Mesoblast Limited?

Mesoblast Limited all-time high quarterly EBITDA is -$3.96 M

What is the all time high TTM EBITDA for Mesoblast Limited?

Mesoblast Limited all-time high TTM EBITDA is -$25.22 M